155 related articles for article (PubMed ID: 21950810)
1. Barrett's esophagus: proton pump inhibitors and chemoprevention II.
Richter JE; Penagini R; Tenca A; Pohl D; Dvorak K; Goldman A; Savarino E; Zentilin P; Savarino V; Watson JT; Wong RK; Pace F; Casini V; Peura DA; Herzig SJ; Kamiya T; Pelosini I; Scarpignato C; Armstrong D; DeVault KR; Bechi P; Taddei A; Freschi G; Ringressi MN; Degli'Innocenti DR; Castiglione F; Masini E; Hunt RH
Ann N Y Acad Sci; 2011 Sep; 1232():114-39. PubMed ID: 21950810
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of chemoprevention with proton pump inhibitors in Barrett's esophagus.
Sharaiha RZ; Freedberg DE; Abrams JA; Wang YC
Dig Dis Sci; 2014 Jun; 59(6):1222-30. PubMed ID: 24795040
[TBL] [Abstract][Full Text] [Related]
3. Barrett's esophagus: proton pump inhibitors and chemoprevention I.
Triadafilopoulos G; Taddei A; Bechi P; Freschi G; Ringressi MN; Degli'Innocenti DR; Castiglione F; Masini E; Majewski M; Wallner G; Sarosiek J; Dillon JF; McCallum RC; Dvorak K; Goldman A; Woodland P; Sifrim D; Richter JE; Vieth M; Neumann H; Langner C; Ishimura N; Amano Y; Felix VN
Ann N Y Acad Sci; 2011 Sep; 1232():93-113. PubMed ID: 21950809
[TBL] [Abstract][Full Text] [Related]
4. The Effect of Proton Pump Inhibitors on Barrett's Esophagus.
Dunbar KB; Souza RF; Spechler SJ
Gastroenterol Clin North Am; 2015 Jun; 44(2):415-24. PubMed ID: 26021202
[TBL] [Abstract][Full Text] [Related]
5. The Role of Acid Suppression in Barrett's Esophagus.
Elias PS; Castell DO
Am J Med; 2017 May; 130(5):525-529. PubMed ID: 28159599
[TBL] [Abstract][Full Text] [Related]
6. Current Status of Chemoprevention in Barrett's Esophagus.
Moayyedi P; El-Serag HB
Gastrointest Endosc Clin N Am; 2021 Jan; 31(1):117-130. PubMed ID: 33213791
[TBL] [Abstract][Full Text] [Related]
7. Chemoprevention of Barrett's oesophagus: a step closer with PPIs and aspirin.
Husain NS; El-Serag HB
Nat Rev Clin Oncol; 2018 Dec; 15(12):728-730. PubMed ID: 30237519
[No Abstract] [Full Text] [Related]
8. Does Barrett's esophagus regress after surgery (or proton pump inhibitors)?
Spechler SJ
Dig Dis; 2014; 32(1-2):156-63. PubMed ID: 24603402
[TBL] [Abstract][Full Text] [Related]
9. Transepithelial leak in Barrett's esophagus patients: the role of proton pump inhibitors.
Farrell C; Morgan M; Tully O; Wolov K; Kearney K; Ngo B; Mercogliano G; Thornton JJ; Valenzano MC; Mullin JM
World J Gastroenterol; 2012 Jun; 18(22):2793-7. PubMed ID: 22719187
[TBL] [Abstract][Full Text] [Related]
10. The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association.
Freedberg DE; Kim LS; Yang YX
Gastroenterology; 2017 Mar; 152(4):706-715. PubMed ID: 28257716
[TBL] [Abstract][Full Text] [Related]
11. Revisiting Proton Pump Inhibitors as Chemoprophylaxis Against the Progression of Barrett's Esophagus.
Shah SL; Dunbar K
Curr Gastroenterol Rep; 2023 Dec; 25(12):374-379. PubMed ID: 37940812
[TBL] [Abstract][Full Text] [Related]
12. Increased acid and bile reflux in Barrett's esophagus compared to reflux esophagitis, and effect of proton pump inhibitor therapy.
Menges M; Müller M; Zeitz M
Am J Gastroenterol; 2001 Feb; 96(2):331-7. PubMed ID: 11232672
[TBL] [Abstract][Full Text] [Related]
13. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
[TBL] [Abstract][Full Text] [Related]
14. Reflux patterns in patients with short-segment Barrett's oesophagus: a study using impedance-pH monitoring off and on proton pump inhibitor therapy.
Frazzoni M; Savarino E; Manno M; Melotti G; Mirante VG; Mussetto A; Bertani H; Manta R; Conigliaro R
Aliment Pharmacol Ther; 2009 Sep; 30(5):508-15. PubMed ID: 19519732
[TBL] [Abstract][Full Text] [Related]
15. Does the treatment of proton pump inhibitors reduce dysplasia or adenocarcinoma development in Barrett's esophagus?
Akın H; Aydın Y
Turk J Gastroenterol; 2017 Dec; 28(Suppl 1):S31-S32. PubMed ID: 29199164
[TBL] [Abstract][Full Text] [Related]
16. Adherence to prescription proton pump inhibitor therapy amongst individuals diagnosed with Barrett's esophagus.
Gaber CE; Abdelaziz AI; Sarker J; Lund JL; Dellon ES; Cotton CC; Eluri S; Shaheen NJ
Pharmacoepidemiol Drug Saf; 2024 Feb; 33(2):e5760. PubMed ID: 38362648
[TBL] [Abstract][Full Text] [Related]
17. Acid suppression medications reduce risk of oesophageal adenocarcinoma in Barrett's oesophagus: a nested case-control study in US male veterans.
Tan MC; El-Serag HB; Yu X; Thrift AP
Aliment Pharmacol Ther; 2018 Aug; 48(4):469-477. PubMed ID: 29956826
[TBL] [Abstract][Full Text] [Related]
18. Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors.
Gerson LB; Boparai V; Ullah N; Triadafilopoulos G
Aliment Pharmacol Ther; 2004 Sep; 20(6):637-43. PubMed ID: 15352912
[TBL] [Abstract][Full Text] [Related]
19. Persistent acid reflux and symptoms in patients with Barrett's oesophagus on proton-pump inhibitor therapy.
Basu KK; Bale R; West KP; de Caestecker JS
Eur J Gastroenterol Hepatol; 2002 Nov; 14(11):1187-92. PubMed ID: 12439112
[TBL] [Abstract][Full Text] [Related]
20. [A comparison of medical versus surgical treatment in Barrett's esophagus acid control].
Fernández Fernández N; Domínguez Carbajo AB; João Matias D; Rodríguez-Martín L; Aparicio Cabezudo M; Monteserín Ron L; Jiménez Palacios M; Vivas S
Gastroenterol Hepatol; 2016 May; 39(5):311-7. PubMed ID: 26545949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
